Pfizer has outperformed the S&P 500 since my previous call, driven by improving fundamentals and renewed share price momentum ...

We recently published 10 Stocks Jim Cramer Talked About . Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer talked ...

More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new medicines, yet other leading pharmaceutical companies are hesitating over what ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...

A new review suggests that the FDA usually followed the science, not politics, when making decisions about the abortion pill mifepristone.

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

The FDA has told the makers of six flu vaccines that they need to add a notification to the label of their shots, warning of ...

The regulator’s Office of Prescription Drug Promotion (OPDP) has already sent out two letters alleging “false or misleading” ...

Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite ...

Pfizer remains a Strong Buy, with oncology breakthroughs, a revitalized obesity pipeline, and aggressive cost savings ...